Does Oramed Pharmaceuticals (ORMP) Pay a Dividend? (2026)

Yes. Oramed Pharmaceuticals pays a dividend yielding roughly 6.00% as of July 2026. The most recent payment on record was $0.25 per share with an ex-dividend date of January 16, 2026. That works out to a forward annual rate of about $0.25 per share. Yields move with the share price, so verify the current figure with your broker or ORMP's investor relations page before relying on it.

About 6.00% as of July 2026. On a $10,000 position that is roughly $600 of dividend income a year before tax. For context, the S&P 500 yields around 1.2%, so ORMP yields meaningfully more than the broad market. A higher yield is not automatically better: it can reflect a falling share price as easily as a generous payout, so it is worth checking why the number is what it is.

Oramed Pharmaceuticals's payment schedule is in the history table above. The most recent payment on record had an ex-dividend date of January 16, 2026. To receive a given payment you have to own the shares before the ex-dividend date, not on the pay date. Confirm upcoming dates on ORMP's investor relations page, because boards can change both the amount and the timing.

The ex-dividend date recorded in our July 2026 data pull is January 16, 2026. The ex-dividend date is the cutoff: buy on or after it and the seller keeps that payment, not you. Buying just before the ex-date to capture the dividend does not create free money, because the share price typically drops by roughly the dividend amount when the stock goes ex. Check ORMP's investor relations page for the next confirmed date.

$0.25 per share in the most recent payment (ex-date January 16, 2026), which annualizes to about $0.25 per share.

Oramed Pharmaceuticals paid out about 10% of its earnings as dividends, so the payout is very well covered. A low ratio means the dividend has plenty of room and the company is keeping most of its profit to reinvest or buy back stock, which is also why the yield is modest. Nobody can guarantee a dividend: boards cut them, and a high yield is sometimes the market pricing in exactly that. Walnut is not an investment adviser and this is not a recommendation.

At a yield of about 6.00%, roughly $600 a year before tax. That is a snapshot, not a promise: the amount changes when the company changes its payout, and your yield on cost is fixed at the price you paid, not at today's price.

Dividends from US common stock are usually qualified, meaning they are taxed at the lower long-term capital-gains rates, provided you held the shares for more than 60 days in the 121-day window around the ex-dividend date. Distributions from REITs, BDCs, and some pass-through structures are generally taxed as ordinary income instead. In an IRA or Roth the question does not arise. See our guide to how dividends are taxed. This is not tax advice.

Most brokers offer automatic reinvestment (a DRIP) that puts each ORMP payment straight back into more shares, often fractional ones. Reinvesting compounds the position and is the standard choice when you do not need the cash yet. Taking the cash makes sense when you are spending the income or want to direct it elsewhere. Either way the dividend is taxable in a taxable account in the year it is paid, even if you never see the money.

As a clinical-stage, pre-revenue biotech, Oramed is not a typical dividend stock, and any capital-return actions are unusual and tied to specific corporate events rather than a regular income program. Investors generally hold it for the possibility of clinical and strategic upside, not for income. Always check the latest filings for any declared distribution before assuming a payout.